跳至主要内容
临床试验/NL-OMON25995
NL-OMON25995招募中不适用

Chemoradiation with gemcitabine in combination with panitumumab for patients with locally advanced pancreatic cancer. A phase I/II study.

Prof. dr. H.M.W. Verheul, M.D., Ph.D.Head Department of Medical OncologyVU University Medical CenterDe Boelelaan 11171081 HV AmsterdamPhone: +31-20-4444321/300Fax: + 31-20-4444079Email: h.verheul@vumc.nl0 个研究点目标入组 63 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
63

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Histological or cytological confirmed pancreatic cancer;
  • 2. Not eligible for curative resection;

排除标准

  • 1. Participation in another therapeutic clinical study within 30 days of enrollment or during this clinical study;
  • 2. No adequate radiation therapy possible: based on the opinion of the radiation oncologist when radiation therapy cannot be performed because radiation field is too large (PTV volume too large or OAR too high);

研究者

发起方
Prof. dr. H.M.W. Verheul, M.D., Ph.D.Head Department of Medical OncologyVU University Medical CenterDe Boelelaan 11171081 HV AmsterdamPhone: +31-20-4444321/300Fax: + 31-20-4444079Email: h.verheul@vumc.nl

相似试验